(Q33386412)

26 July 2017

title

Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients (English)

1 reference

26 July 2017

0 references

1 reference

1 reference

A V Khrunin

1

1 reference

26 July 2017

A Moisseev

series ordinal

2

1 reference

26 July 2017

V Gorbunova

series ordinal

3

1 reference

26 July 2017

S Limborska

series ordinal

4

1 reference

26 July 2017

publication date

29 September 2009

1 reference

The Pharmacogenomics Journal

26 July 2017

published in

1 reference

26 July 2017

volume

10

1 reference

26 July 2017

issue

1

1 reference

26 July 2017

page(s)

54-61

1 reference

https://scigraph.springernature.com/pub.10.1038/tpj.2009.45

26 July 2017

exact match

0 references

cites work

The resurgence of platinum-based cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Molecular mechanisms of resistance and toxicity associated with platinating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Pharmacogenomics--drug disposition, drug targets, and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Cancer pharmacogenomics: international trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Direct cellular responses to platinum-induced DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Glutathione S-transferase polymorphisms: cancer incidence and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Allelic variants of the human glutathione S-transferase P1 gene confer differential cytoprotection against anticancer agents in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Association between glutathione-S-transferase GSTP1 genotypes, GSTP1 over-expression, and outcome in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Coexpression of erythropoietin and erythropoietin receptor in von Hippel-Lindau disease-associated renal cysts and renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

TP53 and P21 polymorphisms: response to cisplatinum/paclitaxel-based chemotherapy in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

The role of glutathione-S-transferase polymorphisms in ovarian cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Moving toward individualized therapy based on NER polymorphisms that predict platinum sensitivity in ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Polymorphism of human mu class glutathione transferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Combined effect of polymorphic GST genes on individual susceptibility to lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: role in mutagen sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Genetic polymorphisms of cytochrome p4502E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a white population: a study and literature review, including meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Glutathione-S-transferase gene polymorphisms in colorectal cancer patients: interaction between GSTM1 and GSTM3 allele variants as a risk-modulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Analysis of cytotoxicities of platinum compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Genetic analysis of glutathione S-transferase A1 polymorphism in the Chinese population and the influence of genotype on enzymatic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Glutathione conjugation of alkylating cytostatic drugs with a nitrogen mustard group and the role of glutathione S-transferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Association between a glutathione S-transferase A1 promoter polymorphism and survival after breast cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Cisplatin-induced long-term hearing impairment is associated with specific glutathione s-transferase genotypes in testicular cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Cancer pharmacogenomics: role of DNA repair genetic polymorphisms in individualizing cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Role of glutathione-S-transferase and codon 72 of P53 genotypes in epithelial ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

Glutathione S-Transferase P1 Polymorphism (Ile105Val) Predicts Cumulative Neuropathy in Patients Receiving Oxaliplatin-Based Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2009.45

21 January 2018

Identifiers

DOI

10.1038/TPJ.2009.45

1 reference

Dimensions Publication ID

26 July 2017

1043532859

0 references

1 reference